Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Lexaria Bioscience Corp. (OTC: LXRP).

Full DD Report for LXRP

You must become a subscriber to view this report.


Recent News from (OTC: LXRP)

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Strategically Disrupting Drug Delivery
Expanding the applicability of edible delivery technology within the drug industry Creating strategic partnerships through licensing agreements Breakthrough in nicotine absorption study supports further investigation into the many possible uses beyond the cannabis and nicotine industrie...
Source: NetworkNewsWire
Date: May, 16 2018 11:30
CannabisNewsBreaks - Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Awaiting Patent for Promising DehydraTECH Transdermal CBD Application
Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) continues to add numerous U.S. and Australian patents to its existing portfolio. Among these is the company’s recent filing for a new transdermal application of cannabidiol (CBD) that followed successful laboratory evaluation of DehydraT...
Source: CannabisNewsWire
Date: May, 14 2018 15:30
NetworkNewsBreaks - Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Awaiting Patent for Promising DehydraTECH Transdermal CBD Application
Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) continues to add numerous U.S. and Australian patents to its existing portfolio. Among these is the company’s recent filing for a new transdermal application of cannabidiol (CBD) that followed successful laboratory evaluation of DehydraT...
Source: NetworkNewsWire
Date: May, 14 2018 15:00
Lexaria Bioscience's (CSE: LXX) (OTCQX: LXRP) Licensing Agreement Renewal with Nuka Enterprises Reinforces DehydraTECH(TM) Revenue Strategy
Report: LXRP is a ‘compelling investment opportunity’ which is creating recurring licensing revenue that unlocks shareholder value LXRP’s DehydraTECH is a patented delivery technology platform that is renewal-licensed by Nuka in a 10-year semi-exclusive agreement that...
Source: NetworkNewsWire
Date: May, 14 2018 12:45
Lexaria Solidifies Presence in Edibles Market with New Agreement -- CFN Media
SEATTLE, Wash., May 04, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering  Lexaria Bioscience Corp.’s   (C...
Source: GlobeNewswire
Date: May, 04 2018 08:44
Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Enters License Agreement with California Cannabis Beverage Maker
Lexaria and GP Holdings LLC enter into a five-year semi-exclusive licensing agreement Lexaria and GP have developed a series of high-performing cannabis beverages with nearly zero unwanted taste and odor California cannabis-beverage market is expected to be one of the largest edible pro...
Source: NetworkNewsWire
Date: May, 03 2018 12:30
Subsidiary Industries Prepare for Growing Cannabis Market
CannabisNewsWire Editorial Coverage : Impending legislation in Canada is the most recent step in the spread of legal cannabis consumption. As the industry grows, so do the support businesses supplying related services for retailers and consumers. Global Payout, Inc. (GOHE) ( GOHE profile ...
Source: CannabisNewsWire
Date: May, 02 2018 09:00
Lexaria's DehydraTECH Builds Market Share in Cannabis Beverage Industry -- CFN Media
SEATTLE, May 01, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering Lexaria Bioscience Corp's . (CSE:LXX) (LXX.CN) (CNSX:LXX) (O...
Source: GlobeNewswire
Date: May, 01 2018 08:38
NetworkNewsBreaks - Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Renews Licensing Agreement with Nuka Enterprises
Drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) recently announced a new licensing agreement with Nuka Enterprises LLC to renew Nuka’s DehydraTECH™ license rights for use in its 1906 brand of cannabis chocolates. Nuka and 1906 have also acquired...
Source: NetworkNewsWire
Date: May, 01 2018 08:30
Lexaria Technology Brings "Fast-Acting" to Nuka's 1906 Cannabis Products with 10-Year Deal Consummating Proof-Of-Concept Relationship. Nuka's 1906 chocolates, utilizing Lexaria's DehydraTECH technology, have been recognized for their fast onset times, eff
(via TheNewswire) Kelowna, British Columbia / TheNewswire / April 30, 2018 - Lexaria Bioscience Corp . (OTCQX: LXRP) (CSE: LXX), an innovator in drug delivery platforms, today announced a major new licensing agreement with Nuka Enterprises LLC, maker of 1906 brand ca...
Source: TheNewsWire
Date: April, 30 2018 16:05

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-141.681.701.741.6555,814
2018-08-131.731.661.7651.6595,859
2018-08-101.751.73251.83751.65119,972
2018-08-091.751.751.751.6854,490
2018-08-081.801.701.801.7083,764

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-1320,71195,85921.6057Cover
2018-08-1034,085119,97228.4108Cover
2018-08-0924,92654,49045.7442Short
2018-08-0815,95183,76419.0428Cover
2018-08-0776,263185,62541.0844Short

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on LXRP.


About Lexaria Bioscience Corp. (OTC: LXRP)

Logo for Lexaria Bioscience Corp. (OTC: LXRP)

Lexaria Bioscience Corp. has developed and out licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds. Lexaria has multiple patents pending and granted in over countries around the world and was granted its first patent in the USA in October. . Lexaria s technology provides increases of up to Ox in intestinal absorption rates more rapid delivery to the bloodstream with effects often with in minutes and important taste masking benefits for orally administered bioactive molecules including but not limited to cannabinoids, vitamins, NSAIDs, and nicotine.

 

 

 

Current Management

  • Chris Andrew Bunka / CEO
  • John Docherty / President
  • Allan Horst Spissinger / CFO
  • Chris Andrew Bunka / Chairman
  • Nicholas Wilson Baxter / Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
  • John Docherty /
  • William Edward McKechnie / Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member

Current Share Structure

  • Market Cap: $96,478,755 - 03/09/2018
  • Authorized: 220,000,000 - 11/30/2016
  • Issue and Outstanding: 69,912,141 - 12/22/2017
  • Float: 42,152,370 - 02/28/2017

 


Recent Filings from (OTC: LXRP)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 04 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 26 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 19 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 13 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: April, 12 2018
Prospectus filed under Rule 424(b)(3)
Filing Type: 424B3Filing Source: edgar
Filing Date: April, 09 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 28 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 23 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 16 2018
Notice from the SEC of registration effectiveness
Filing Type: EFFECTFiling Source: edgar
Filing Date: March, 07 2018

 

 


Daily Technical Chart for (OTC: LXRP)

Daily Technical Chart for (OTC: LXRP)


Stay tuned for daily updates and more on (OTC: LXRP)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: LXRP)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in LXRP is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of LXRP and does not buy, sell, or trade any shares of LXRP. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/